Risk assessment and prevention in cardiomyopathies

• by Elena Cavarretta, Victor Aboyans

• September 8, 2025

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

• by Kathryn Wighton

• May 27, 2026

• 6 min

Risk-score performance for detecting transthyretin cardiac amyloidosis in severe aortic stenosis: a prospective cohort study

• by Graczyk Katarzyna, Dziewięcka Ewa, Winiarczyk Mateusz, Stępień Agnieszka, Przytuła Natalia, Holcman Katarzyna, Wiśniowska-Śmiałek Sylwia, Szot Wojciech, Kostkiewicz Magdalena, Rubiś Paweł

• May 22, 2026

Recognizing the Transition to Advanced Heart Failure Earlier

Despite major advances in guideline-directed medical therapy (GDMT), worsening heart failure continues to drive significant morbidity, repeat hospitalizations and healthcare utilization worldwide.

• by

• May 27, 2026

• 6 min